Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-1 domain

Journal of Cellular Physiology

Volumn 214, Issue 1, 2008, Pages 250-259

  Hamma Kourbali, Yamina ^a   Bernard Pierrot, Isabelle ^a,d   Heroult, Mélanie ^a,e   Dalle, Sophie ^a   Caruelle, Danièle ^a   Milhiet, Pierre Emmanuel ^b   Fernig, David G ^c   Delbé, Jean ^a   Courty, José ^a  

^a Université Paris XII ^*  (France)

^b CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d INSTITUT CURIE   (France)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLUTAMYLCYSTEINYLLYSYLTYROSYLGLUTAMINYLPHENYLALANYL GLUTAMINYLALANYLTRYPTOPHYLGLYCYLGLUTAMYLCYSTEINYLASPARTYLLEUCYLASPARAGINYL THREONYLALANYLLEUCYLLYSYLTHREONYLARGINYLTHREONYLGLYCYLSERYLLEUCYLLYSYLARGINYL ALANYLLEUCYLHISTIDYLASPARAGINYLALANINE; ANGIOGENESIS INHIBITOR; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; FIBROBLAST GROWTH FACTOR 2; HEPARIN; PEPTIDE DERIVATIVE; PLEIOTROPHIN; SERYLASPARTYLCYSTEINYLGLYCYLGLUTAMYLTRYPTOPHYLGLUTAMINYLTRYPTOPHYL SERYLVALYLCYSTEINYLVALYLPROLYLTHREONYLSERYLGLYCYLASPARTYLCYSTEINYLGLYCYL LEUCYLGLYCYLTHREONYLARGINYLGLUTAMYLGLYCYLTHREONYLARGININE; THROMBOSPONDIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG BINDING; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; MOUSE; NONHUMAN; OPTICAL BIOSENSOR; PRIORITY JOURNAL; PROTEIN MOTIF; TUMOR;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HUMANS; MICE; MICE, NUDE; MITOSIS; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; NIH 3T3 CELLS; PEPTIDES; PROTEIN BINDING; RECOMBINANT PROTEINS; THROMBOSPONDINS; TRANSPLANTATION, HETEROLOGOUS; UMBILICAL VEINS;

EID: 36849053590     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21191     Document Type: Article

References (41)

1. Bernard-Pierrot I, Heroult M, Lemaitre G, Barritault D, Courty J, Milhiet PE. 1999. Glycosaminoglycans promote HARP/PTN dimerization. Biochem Biophys Res Commun 266:437-442.
2. Bernard-Pierrot I, Delbe J, Caruelle D, Barritault D, Courty J, Milhiet PE. 2001. The lysine-hch C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities. J Biol Chem 276:12228-12234.
3. Bernard-Pierrot I, Delbe J, Rouet V, Vigny M, Kerros ME, Caruelle D, Raulais D, Barritault D, CourtyJ, Milhiet PE. 2002. Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities. J Biol Chem 277:32071-32077.
4. Chauhan AK, Li YS, Deuel TF. 1993. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proceedings of the National Academy of Sciences of the United States of America 90:679-682.
5. Courty J, Milhiet PE, Delbe J, Caruelle D, Barritault D. 2000. Heparin-affin regulatory peptide, HARP Bikfalvi A, editor. Springer. 145-152 p.
6. Dauchel MC, Courty J, Mereau A, Barritault D. 1989. Modulation of mitogenic activity and cellular binding of basic fibroblast growth factor by basic proteins. J Cell Biochem 39:411-420.
7. Delbe J, Vacherot F, Laaroubi K, Barritault D, Courty J. 1995. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide. J Cell Physiol 164:47-54.
8. Delehedde M, Lyon M, Sergeant N, Rahmoune H, Fernig DG. 2001. Proteoglycans: Pericellular and cell surface multireceptors that integrate external stimuli. J Mammary Gland Biol 6:253-273.
9. Delehedde M, Lyon M, Gallagher JT, Rudland PS, Fernig DG. 2002a. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. Biochem J 366:235-244.
10. Delehedde M, Lyon M, Vidyasagar R, McDonnell TJ, Fernig DG. 2002b. Hepatocyte growth factor/scatter factor binds to small heparin-derived oligosaccharides and stimulates the proliferation of human HaCaT keratinocytes. J Biol Chem 277:12456-12462.
11. Duchesne L, Tissot B, Rudd TR, Dell A, Fernig DG. 2006. N-Glycosylation of fibroblast growth factor receptor I regulates ligand and heparan sulfate co-receptor binding. J Biol Chem 281:27178-27189.
12. Edwards PR, Leatherbarrow RJ. 1997. Determination of association rate constants by an optical biosensor using initial rate analysis. Anal Biochem 246:1-6.
13. Fernig DG. 2001. Analysis of protein-polysaccharide interactions using optical biosensor techniques. In: Iozzo RV, editor. Proteoglycan protocols. Totowa, NJ: Humana Press. p 505-518.
14. Heroult M, Bernard-Pierrot I, Delbe J, Hamma-Kourbali Y, Katsoris P, Barritault D, Papadimitriou E, Plouet J, Courty J. 2004. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Oncogene 23:1745-1753.
15. Kilpelainen I, Kaksonen M, Avikainen H, Fath M, Linhardt RJ, Raulo E, Rauvala H. 2000. Heparin-binding growth-associated molecule contains two heparin-binding beta-sheet domains that are homologous to the thrombospondin type I repeat. J Biol Chem 275:13564-13570.
16. Kinnunen T, Kaksonen M, Saarinen J, Kalkkinen N, Peng HB, Rauvala H. 1998. Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J Biol Chem 273:10702-10708.
17. Kinsella MG, Irvin C, Reidy MA, Wight TN. 2004. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries. Atherosclerosis 175:51-57.
18. Kojima S, Inui T, Kimura T, Sakakibara S, Muramatsu H, Amanuma H, Maruta H, Muramatsu T. 1995. Synthetic peptides derived from midkine enhance plasminogen activator activity in bovine aortic endothelial cells. Biochem Biophys Res Commun 206:468-473.
19. Maeda N, Noda M. 1998. Involvement of receptor-like protein tyrosine phosphatase zeta/RPTP beta and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration. J Cell Biol 142:203-216.
20. Maeda N, Nishiwaki T, Shintani T, Hamanaka H, Noda M. 1996. 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J Biol Chem 271:21446-21452.
21. Mohammadi M, Olsen SK, Goetz R. 2005. A protein canyon in the FGF-FGF receptor dimer selects from an a la carte menu of heparan sulfate motifs. Curr Opin Struct Biol 15:506-516.
22. Papadimitriou E, Polykratis A, Hatziapostolou M, Parthymou A, Polytarchou C, Mikelis C. 2004. Heparin affin regulatory peptide: A new target for tumour therapy? Curr Cancer Drug Targets 4:471-482.
23. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67:519-528.
24. Pavlov I, Voikar V, Kaksonen M, Lauri SE, Hienola A, Taira T, Rauvala H. 2002. Role of heparin-binding growth-associated molecule (HB-GAM) in hippocampal LTP and spatial learning revealed by studies on overexpressing and knockout mice. Mol Cell Neurosci 20:330-342.
25. Powell AK, Yates EA, Fernig DG, Turnbull JE. 2004. Interactions of heparin/heparan sulfate with proteins: Appraisal of structural factors and experimental approaches. Glycobiology 14:17R-30R.
26. Powers C, Aigner A, Stoica GE, McDonnell K, Wellstein A. 2002. Pleiotropen signaling through anaplastic lymphoma kinase (ALK) is rate-limiting for glioblastoma growth. J Biol Chem 23:23.
27. Rahmoune H, Gallagher JT, Rudland PS, Fernig DG. 1998a. Hepatocyte growth factor/scatter factor has distinct classes of binding site in heparan sulfate from mammary cells. Biochemistry 37:6003-6008.
28. Rahmoune H, Gallagher JT, Rudland PS, Fernig DG. 1998b. Interaction of heparan sulphate from mammary cells with extracellular regulatory proteins. Acidic and fibroblast growth factor: Regulation of the activity of bFGF by high and low affinity binding sites in heparan sulphate. J Biol Chem 273:7303-7310.
29. Raulo E, Chernousov MA, Carey DJ, Nolo R, Rauvala H. 1994. Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J Biol Chem 269:12999-13004.
30. Raulo E, Tumova S, Pavlov I, Pekkanen M, Hienola A, Klankki E, Kalkkinen N, Taira T, Kilpelainen I, Rauvala H. 2005. The two thrombospondin type I repeat domains of the heparin-binding growth-associated molecule bind to heparin/heparan sulfate and regulate neurite extension and plasticity in hippocampal neurons. J Biol Chem 280:41576-41583.
31. Rauvala H. 1989. An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J 8:2933-2941.
32. Rich RL, Myszka DG. 2005. Survey of the year 2003 commercial optical biosensor literature. J Mol Recognit 18:1-39.
33. Sadir R, Forest E, Lortat-Jacob H. 1998. The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma- interferon-gamma receptor complex formation. J Biol Chem 273:10919-10925.
34. Said EA, Courty J, Svab J, Delbe J, Krust B, Hovanessian AG. 2005. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FEBS J 272:4646-46S9.
35. Schuck P. 1997. Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. Annu Rev Biophys Biomol Struct 26:541-566.
36. Soulie P, Heroult M, Bernard I, Kerros ME, Milhiet PE, DelbeJ, Barritault D, Caruelle D, Courty J. 2002. Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids. J Immunoassay Immunochem 23:33-48.
37. Stoica GE, Kuo A, Aigner A, Sunitha I, Souttou B, Malerczyk C, Caughey DJ, Wen D, Karavanov A, Riegel AT, Wellstein A. 2001. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J Biol Chem 276:16772-16779.
38. Vacherot F, Caruelle D, Chopin D, Gil-Diez S, Barritault D, Caruelle JP, Courty J. 1999a. Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate 38:126-136.
39. Vacherot F, Delbe J, Heroult M, Barritault D, Fernig DG, Courty J. 1999b. Glycosaminoglycans differentially bind HARP and modulate its biological activity. J Biol Chem 274:7741-7747.
40. Vanderwinden JM, Mailleux P, Schiffmann SN, Vanderhaeghen JJ. 1992. Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues. Anatomy Embryol 186:387-406.
41. West DC, Rees CG, Duchesne L, Patey SJ, Terry CJ, Turnbull JE, Delehedde M, Heegaard CW, Allain F, Vanpouille C, Ron D, Fernig DG. 2005. Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem 280:13457-13464.